efficacy of early and late term imitation of prophylactic enoxaparin in prevention of thrombotic event and prevalence of hemorrhagic complications in patients with chronic subdural hematoma

Comparative efficacy of early and late term imitation of prophylactic enoxaparin in prevention of thrombotic event and prevalence of hemorrhagic complications in patients with chronic subdural hematoma treated with Burr-hole craniostomy approach

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200207046400N1

Enrollment

Registered

2020-06-13

Start date

2020-03-20

Completion date

Unknown

Last updated

2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic subdural haematoma. Chronic subdural haematoma

Interventions

Intervention 1: Intervention group: Enoxaparin with a prophylactic dose 24 hours per day at a dose of 1 mg / kg (maximum 40 mg). Intervention 2: Control group: Enoxaparin with a prophylactic dose 72 h

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients who have been diagnosed with Chronic subdural haematoma who undergo surgical evacuation Patient consent

Exclusion criteria

Exclusion criteria: contraindications to receive enoxaparin occurrence of existence of deep venous thrombus in the period of study existence of hematoma in post operative brain CT scan

Design outcomes

Primary

Measure	Time frame
Bleeding events (epidural and cerebral hematoma). Timepoint: 24 , 72 hours after surgery by craniotomy. Method of measurement: Brain CT scan.;Thrombotic events. Timepoint: 24 , 72 hours after surgery by craniotomy. Method of measurement: Double-sided Doppler ultrasound of the lower extremities.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mehdi Shafiei

Esfahan University of Medical Sciences

Mehdishafiei82@gmail.com+98 31 3668 0048

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026